Evidence map›Paper›PMID 20731711›Full record

ArticleThe European journal of neuroscience2010

Roles of light and serotonin in the regulation of gastrin-releasing peptide and arginine vasopressin output in the hamster SCN circadian clock.

Jessica M Francl, Gagandeep Kaur, J David Glass

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Circuit development in the master clock network of mammals.The European journal of neuroscience · 2020
    Review
  4. Article
  5. Article
  6. KScientific reports · 2017
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jessica M FranclDepartment of Biological Sciences, Kent State University, Kent, OH 44242, USA.
Gagandeep Kaur
J David Glass
Kent State University · US

Funding

NEUROLOGIC REGULATION OF THE SCN CIRCADIAN CLOCKR01NS035229 · NINDS · KENT STATE UNIVERSITY AT KENT · PI GLASS, JOHN DAVID · 1997 to 2009
$2.8M
NINDS NIH HHS NS-35229NINDS NIH HHS R01 NS035229
6 · The paper itself

Abstract

Daily timing of the mammalian circadian clock of the suprachiasmatic nucleus (SCN) is regulated by photic input from the retina via the retinohypothalamic tract. This signaling is mediated by glutamate, which activates SCN retinorecipient units communicating to pacemaker cells in part through the release of gastrin-releasing peptide (GRP). Efferent signaling from the SCN involves another SCN-containing peptide, arginine vasopressin (AVP). Little is known regarding the mechanisms regulating these peptides, as literature on in vivo peptide release in the SCN is sparse. Here, microdialysis-radioimmunoassay procedures were used to characterize mechanisms controlling GRP and AVP release in the hamster SCN. In animals housed under a 14/10-h light-dark cycle both peptides exhibited daily fluctuations of release, with levels increasing during the morning to peak around midday. Under constant darkness, this pattern persisted for AVP, but rhythmicity was altered for GRP, characterized by a broad plateau throughout the subjective night and early subjective day. Neuronal release of the peptides was confirmed by their suppression with reverse-microdialysis perfusion of calcium blockers and stimulation with depolarizing agents. Reverse-microdialysis perfusion with the 5-HT(1A,7) agonist 8-OH-DPAT ((±)-8-hydroxydipropylaminotetralin hydrobromide) during the day significantly suppressed GRP but had little effect on AVP. Also, perfusion with the glutamate agonist NMDA, or exposure to light at night, increased GRP but did not affect AVP. These analyses reveal distinct daily rhythms of SCN peptidergic activity, with GRP but not AVP release attenuated by serotonergic activation that inhibits photic phase-resetting, and activated by glutamatergic and photic stimulation that mediate this phase-resetting.

Indexed as

Light8-Hydroxy-2-(di-n-propylamino)tetralinAnimalsArginine VasopressinCircadian ClocksCricetinaeExcitatory Amino Acid AgonistsGastrin-Releasing PeptideMaleMesocricetusMicrodialysisN-MethylaspartatePhotic StimulationSerotoninSerotonin Receptor AgonistsSuprachiasmatic Nucleus8-Hydroxy-2-(di-n-propylamino)tetralinArginine VasopressinExcitatory Amino Acid AgonistsGastrin-Releasing PeptideN-MethylaspartateSerotoninSerotonin Receptor Agonists

Identifiers

PMID20731711
PMCPMC2970749
OpenAlexW2127485377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.